| Peer-Reviewed

Spinal Anesthesia with Low Doses of Hyperbaric Bupivacaine is Safe and Necessary in Brachytherapy for Carcinoma of the Cervix

Received: 9 March 2018     Accepted: 26 March 2018     Published: 4 May 2018
Views:       Downloads:
Abstract

Background and objectives: Cervical cancer occupies the third place among women. In advanced cases the treatment of choice is brachytherapy and pain is among the most frequent complaints of treatment. The objective of the study was to compare the incidence of pelvic pain and satisfaction among groups of patients submitted to brachytherapy with and without anesthesia. METHODS: Prospective, longitudinal study at a SUS hospital with 30 patients undergoing brachytherapy between the ages of 18 and 60 divided into three groups: GN (without anesthesia), GR5 (spinal anesthesia with 5 mg of hyperbaric bupivacaine 0.5%) and GR10 (spinal anesthesia with 10 mg of 0.5% hyperbaric bupivacaine). Pain was evaluated immediately after brachytherapy (T1), 30 minutes (T2) and before discharge from the post-anesthetic recovery room (T3), through visual analogue scale and satisfaction with the technique. Effects of both doses administered. RESULTS: In the GN 70%, 50% and 10% felt pain, respectively, in T1, T2 and T3; in GR5 no patient presented pain in the 3 times studied; in GR10, only one patient had pain in T1. Regarding satisfaction, in GN 20% was poor, 60% satisfactory and 20% good; in GR5 100% was good; in GR10, 60% was satisfactory, 40% good. CONCLUSION: Spinal anesthesia with low doses of hyperbaric bupivacaine is safe and necessary in BTCC. In conclusion, after this small study, spinal anesthesia became routine in this procedure and possibly to be implanted in all Brazilian Health System (SUS) units.

Published in American Journal of Applied Scientific Research (Volume 4, Issue 1)
DOI 10.11648/j.ajasr.20180401.11
Page(s) 1-4
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2018. Published by Science Publishing Group

Keywords

Spinal Anesthesia, Hyperbaric Bupivacaine, Brachytherapy, Ambulatory

References
[1] INCA-Instituto Nacional de Câncer José de Alencar Gomes da Silva. www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/colo_utero/definição. Acesso em 15 janeiro 2018.
[2] INCA-Instituto Nacional de Câncer José de Alencar Gomes da Silva. Estimativa 2016: incidência de câncer no Brasil – Rio de Janeiro: INCA, 2015.
[3] Benrath J, Kozek-Langenecker S, Hüpfl M, Lierzy P, Gustorff B. Anaesthesia for brachytherapy—51⁄2 yr of experience in 1622 procedures. Br J Anaesth, 2006; 96 (2): 195-200.
[4] Almeida LHRB, Pereira YBAS, Oliveira TA. Radiotherapy: perception of women with uterine-cervical cancer. Rev Bras Enferm, 2008; 61(4): 482-487.
[5] Dahl V, Raeder J. Regional anaesthesia in ambulatory surgery. Curr Opin Anaesthesiol, 2003; 16: 471-476.
[6] Smith MD, Todd JG, Symonds RP. Analgesia for pelvic brachytherapy. Br J Anaesthesiol 2002; 88: 270-276.
[7] R Jain, S Mishra, S Bhatnagar. Comparison of different anaesthetic techniques for high-dose-rate intracavitory. Radiotherapy for carcinoma cervix. The Internet Journal of Anesthesiology, 2007; 17 (1): 1-6.
[8] Imbelloni LE, Sobral MGC, Carneiro ANG. Postdural puncture headache and spinal needle design. Experience in 5050 Cases. Rev Bras Anestesiol, 2001; 51 (1): 43-52.
[9] Axelsson KH, Widman GB, Sundberg AE, Hallgren S. A double blind study of motor blockade in the lower limbs: studies during spinal anaesthesia with hyperbaric bupivacaine. Br J Anaesth, 1985; 57: 960-970.
[10] Lammering EAG, de Bock GH, Pras E, Reyners AKL, Mourits MJE. Sexual functioning of cervical cancer survivors: A review with a female perspective. Maturitas Eur Menopause J, 2012; 72 (4); 296-304.
Cite This Article
  • APA Style

    Siddharta Lacerda, Luiz Eduardo Imbelloni, Maria das Graças Dantas Lima. (2018). Spinal Anesthesia with Low Doses of Hyperbaric Bupivacaine is Safe and Necessary in Brachytherapy for Carcinoma of the Cervix. American Journal of Applied Scientific Research, 4(1), 1-4. https://doi.org/10.11648/j.ajasr.20180401.11

    Copy | Download

    ACS Style

    Siddharta Lacerda; Luiz Eduardo Imbelloni; Maria das Graças Dantas Lima. Spinal Anesthesia with Low Doses of Hyperbaric Bupivacaine is Safe and Necessary in Brachytherapy for Carcinoma of the Cervix. Am. J. Appl. Sci. Res. 2018, 4(1), 1-4. doi: 10.11648/j.ajasr.20180401.11

    Copy | Download

    AMA Style

    Siddharta Lacerda, Luiz Eduardo Imbelloni, Maria das Graças Dantas Lima. Spinal Anesthesia with Low Doses of Hyperbaric Bupivacaine is Safe and Necessary in Brachytherapy for Carcinoma of the Cervix. Am J Appl Sci Res. 2018;4(1):1-4. doi: 10.11648/j.ajasr.20180401.11

    Copy | Download

  • @article{10.11648/j.ajasr.20180401.11,
      author = {Siddharta Lacerda and Luiz Eduardo Imbelloni and Maria das Graças Dantas Lima},
      title = {Spinal Anesthesia with Low Doses of Hyperbaric Bupivacaine is Safe and Necessary in Brachytherapy for Carcinoma of the Cervix},
      journal = {American Journal of Applied Scientific Research},
      volume = {4},
      number = {1},
      pages = {1-4},
      doi = {10.11648/j.ajasr.20180401.11},
      url = {https://doi.org/10.11648/j.ajasr.20180401.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajasr.20180401.11},
      abstract = {Background and objectives: Cervical cancer occupies the third place among women. In advanced cases the treatment of choice is brachytherapy and pain is among the most frequent complaints of treatment. The objective of the study was to compare the incidence of pelvic pain and satisfaction among groups of patients submitted to brachytherapy with and without anesthesia. METHODS: Prospective, longitudinal study at a SUS hospital with 30 patients undergoing brachytherapy between the ages of 18 and 60 divided into three groups: GN (without anesthesia), GR5 (spinal anesthesia with 5 mg of hyperbaric bupivacaine 0.5%) and GR10 (spinal anesthesia with 10 mg of 0.5% hyperbaric bupivacaine). Pain was evaluated immediately after brachytherapy (T1), 30 minutes (T2) and before discharge from the post-anesthetic recovery room (T3), through visual analogue scale and satisfaction with the technique. Effects of both doses administered. RESULTS: In the GN 70%, 50% and 10% felt pain, respectively, in T1, T2 and T3; in GR5 no patient presented pain in the 3 times studied; in GR10, only one patient had pain in T1. Regarding satisfaction, in GN 20% was poor, 60% satisfactory and 20% good; in GR5 100% was good; in GR10, 60% was satisfactory, 40% good. CONCLUSION: Spinal anesthesia with low doses of hyperbaric bupivacaine is safe and necessary in BTCC. In conclusion, after this small study, spinal anesthesia became routine in this procedure and possibly to be implanted in all Brazilian Health System (SUS) units.},
     year = {2018}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Spinal Anesthesia with Low Doses of Hyperbaric Bupivacaine is Safe and Necessary in Brachytherapy for Carcinoma of the Cervix
    AU  - Siddharta Lacerda
    AU  - Luiz Eduardo Imbelloni
    AU  - Maria das Graças Dantas Lima
    Y1  - 2018/05/04
    PY  - 2018
    N1  - https://doi.org/10.11648/j.ajasr.20180401.11
    DO  - 10.11648/j.ajasr.20180401.11
    T2  - American Journal of Applied Scientific Research
    JF  - American Journal of Applied Scientific Research
    JO  - American Journal of Applied Scientific Research
    SP  - 1
    EP  - 4
    PB  - Science Publishing Group
    SN  - 2471-9730
    UR  - https://doi.org/10.11648/j.ajasr.20180401.11
    AB  - Background and objectives: Cervical cancer occupies the third place among women. In advanced cases the treatment of choice is brachytherapy and pain is among the most frequent complaints of treatment. The objective of the study was to compare the incidence of pelvic pain and satisfaction among groups of patients submitted to brachytherapy with and without anesthesia. METHODS: Prospective, longitudinal study at a SUS hospital with 30 patients undergoing brachytherapy between the ages of 18 and 60 divided into three groups: GN (without anesthesia), GR5 (spinal anesthesia with 5 mg of hyperbaric bupivacaine 0.5%) and GR10 (spinal anesthesia with 10 mg of 0.5% hyperbaric bupivacaine). Pain was evaluated immediately after brachytherapy (T1), 30 minutes (T2) and before discharge from the post-anesthetic recovery room (T3), through visual analogue scale and satisfaction with the technique. Effects of both doses administered. RESULTS: In the GN 70%, 50% and 10% felt pain, respectively, in T1, T2 and T3; in GR5 no patient presented pain in the 3 times studied; in GR10, only one patient had pain in T1. Regarding satisfaction, in GN 20% was poor, 60% satisfactory and 20% good; in GR5 100% was good; in GR10, 60% was satisfactory, 40% good. CONCLUSION: Spinal anesthesia with low doses of hyperbaric bupivacaine is safe and necessary in BTCC. In conclusion, after this small study, spinal anesthesia became routine in this procedure and possibly to be implanted in all Brazilian Health System (SUS) units.
    VL  - 4
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Hospital Estadual of Trauma, Jo?o Pessoa, Brazil

  • Hospital Estadual of Trauma, Jo?o Pessoa, Brazil

  • Sections